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In this paper, an on-line aptamer affinity solid-phase extraction capillary 
electrophoresis-mass spectrometry method is described for the purification, 
preconcentration, separation, and characterization of α-synuclein (α-syn) in blood at the 
intact protein level. A single-stranded DNA aptamer is used to bind with high affinity 
and selectivity α-syn, which is a major component of Lewy bodies, the typical 
aggregated protein deposits found in Parkinson’s disease (PD). Under the conditions 
optimized with recombinant α-syn, repeatability (2.1 and 5.4% percent relative standard 
deviation for migration times and peak areas, respectively) and microcartridge lifetime 
(around 20 analyses/microcartridge) were good, the method was linear between 0.5 and 
10 µg·mL-1 and limit of detection was 0.2 µg·mL-1 (100 times lower than by CE-MS, 20 
µg·mL-1). The method was subsequently applied to the analysis of endogenous α-syn 




Capillary electrophoresis-mass spectrometry (CE-MS) is regarded nowadays as a 
powerful technique for the highly efficient separation and characterization of 
biomolecules, including peptides, protein isoforms and post-translational modifications 
(PTMs) or protein complexes1–4. However, as in many other microscale separation 
techniques, the small sample volume injected for optimum separation (typically 1-2% of 
the capillary volume) compromises the concentration sensitivity for most analytes and is 
very often a limitation that hinders a more widespread application5–9. To improve the 
limits of detection (LODs), the use of more selective and sensitive mass spectrometers 
is in many cases not satisfactory enough. Therefore, for the on-line preconcentration of 
the target analytes after the injection of a large volume of sample, CE-MS has been 
often combined with different electrophoretic5,6 and chromatographic6–9 techniques. 
Within the chromatographic preconcentration techniques, on-line solid-phase extraction 
capillary electrophoresis (SPE-CE) is widely recognized as an excellent option to 
preconcentrate and clean up the target analytes, minimizing sample handling and 
increasing analysis throughput. In the most widely used SPE-CE configuration, a 
microcartridge with an appropriate sorbent to selectively retain the target analyte is 
integrated in-line near the entrance of the separation capillary and no valves are 
necessary for the operation. After loading a large volume of sample (∼50-100 μL), the 
capillary is rinsed to eliminate non-retained molecules and filled with background 
electrolyte (BGE). Then, the analyte is eluted and preconcentrated in a small volume of 
an appropriate solution (~25-50 nL) before the separation and the detection8,9.  
Nowadays, the availability of a wide variety of commercial or lab-made sorbents 
has broadened the applicability of SPE-CE. SPE-CE has been explored using 
conventional chromatographic sorbents (e.g. C18 or HLB)7–9, but there is an urgent 




fluids9–15. Immunoaffinity (IA) sorbents prepared by immobilization of antibodies or 
antibody fragments are for many authors the gold standard within the high selective 
sorbents and can provide excellent sample clean-up and extraction efficiency. However, 
the applicability of IA-SPE-CE-MS is limited by several constraints related to the 
conditions needed to guarantee the antibody stability. On-line MS detection is 
negatively affected by the presence of salts due to ionization suppression and requires 
the use of volatile solutions and BGEs to prevent salt build-up. The typically acidic 
BGEs used in CE-MS in positive electrospray ionization (ESI+) mode (e.g. from 0.1 to 
1 M of acetic acid) may cause antibody denaturation, therefore, compromising IA 
sorbent stability. This issue is usually solved using neutral BGEs (e.g. 10 mM of 
ammonium acetate), but ionization efficiency is in general lower under these conditions. 
As an interesting alternative to antibodies, the use of aptamer-based sorbents has been 
proposed for sample preparation16. The most common aptamers are single-stranded 
oligonucleotides that are able to bind to a target molecule with high-affinity and 
selectivity. These features enable their application in diagnostics, imaging, therapeutics, 
targeted delivery, and biosensing17–20. In general, aptamers are isolated in vitro via 
systematic evolution of ligands by exponential enrichment (SELEX), an iterative cycle 
of selection and amplification steps that enriches high-affinity and selective aptamers 
from a large combinatorial library20,21. Aptamers have been generated for a wide variety 
of targets, ranging from simple inorganic molecules to proteins and whole cells20,21. 
Aptamers are chemically synthesized, which eliminates the requirement of animals or 
cells and the possible batch-to-batch variations associated with antibodies, and are 
significantly faster and cheaper to produce20. Other interesting advantages of aptamers 
are robustness, thermal stability, tolerance to wide ranges of pH and salt concentration. 




various functional groups and spacer arms to facilitate the covalent immobilization with 
an appropriate orientation and minimal steric hindrance on a solid support16,22.  
The use of aptamer affinity (AA) sorbents has been previously described for off-
line solid phase microextraction (SPME)23, on-chip SPE24, and on-line SPE-nanoLC22. 
Recently, Marechal et al.14 described an aptamer silica-based monolithic microcartridge 
for the analysis of ochratoxin A in standards, beer and wine by AA-SPE-CE with laser 
induced fluorescence (LIF) detection. So far, to the best of our knowledge, no other 
applications of AA-SPE-CE have been described. 
In this paper, AA-SPE-CE-MS is described for the first time and a method for 
the analysis of α-synuclein (α-syn) in blood is developed. α-Syn is a 14 kDa protein, 
composed of 140 amino acids and numerous proteoforms, including PTMs as 
phosphorylation, ubiquitination, nitration, and acetylation25–27. It is present at high 
levels in the brain where it is mainly localized in presynaptic terminals of nerve cells25, 
but it can be also found in biological fluids such as cerebrospinal fluid (CSF), blood and 
saliva28,29. The potential of certain α-syn proteoforms as biomarkers for early diagnosis 
and tracking progression of Parkinson’s disease (PD), one of the most common 
neurodegenerative motor disorders, is continuously investigated. Phosphorylated α-syn 
at Ser-129 is a major component (90% of α-syn) in the aggregates of Lewy bodies (LB), 
which represent the morphological hallmark of PD25. In contrast, full-length N-terminal 
acetylated α-syn is the major proteoform in brain cytosol whereas phosphorylated α-syn 
involves only about 4% of normal α-syn25. α-Syn has been frequently analyzed in brain 
tissue or CSF26,30. However, more accessible biofluids, such as blood, are also being 
investigated30,31, where it is still necessary to broaden the knowledge about the different 
proteoforms using novel, sensitive and selective analytical methods, as the one proposed 





Materials and reagents 
All the chemicals used in the preparation of background electrolytes (BGEs) and 
solutions were of analytical reagent grade or better. Acetic acid (HAc) (glacial), 
ammonium hydroxide (NH4OH) (25%), formic acid (HFor) (99.0%), potassium 
chloride (99.0%), potassium dihydrogenphosphate (≥99.0%), sodium chloride 
(≥99.5%), and sodium hydrogenphosphate (≥99.0%), were purchased from Merck 
(Darmstadt, Germany). Acetonitrile (LC-MS), and ethanol (96%) were supplied by 
Panreac AppliChem (Barcelona, Spain). Ammonium acetate (NH4Ac) (≥99.9%), and 
Tween® 20 were supplied by Sigma-Aldrich (Steinheim, Germany). Propan-2-ol (LC-
MS) was purchased from Scharlau (Barcelona, Spain). Water (LC-MS grade) was 
supplied by Fisher Scientific (Loughborough, UK). 
The DNA aptamer M5-1532 modified with a C6 spacer arm terminated by 
5’amino (M5-15-5’, 66-mer, Mr = 20,690) and the masking DNA (T-SO508
33, an off-
target sequence single-stranded DNA that tested negative for -syn by AA-SPE-CE-MS 
and was already available in the laboratory, 24-mer, Mr = 7708), both purified by HPLC, 
were purchased from Integrated DNA Technologies (Coralville, IA, USA). 
Magnetic beads (MBs) LOABeads™ AffiAmino of 45-165 µm diameter were 
purchased from Lab on a Bead (Uppsala, Sweden).  
 
Electrolyte solutions, sheath liquid, protein standards and blood samples. 
All the solutions were degassed for 10 min by sonication before use. The 
optimized BGE for the CE-MS and AA-SPE-CE-MS separation contained 100 mM 
HAc (pH 2.9). The BGE was passed through a 0.20 µm nylon filter (Macherey-Nagel, 




propan-2-ol/water with 0.05% (v/v) of HFor and was delivered at a flow rate of 3.3 
µL·min-1 by a KD Scientific 100 series infusion pump (Holliston, MA, USA). 
Recombinant human α-syn expressed in Escherichia coli was purchased from 
Analytik Jena (Jena, Germany). The solution provided by the manufacturer (5000 
µg·mL-1 in phosphate buffered saline (PBS)) was aliquoted and stored in a freezer at -
20ºC. Aliquots were thawed before use and working standard solutions were prepared 
by dilution in water. These solutions were stored in the fridge at 5ºC when not in use. 
Human blood samples from patients were provided by the Basque 
Biobank/Biodonostia Node (www.biobancovasco.org). Samples were processed 
following standard operation procedures with appropriate approval of the Ethical and 
Scientific Committees. Three healthy donor blood samples and three PD patient blood 
samples (one at stage III and two at stage IV of the disease) were analyzed. All the 
samples corresponded to males and females aged between 60 and 80 years.  
 
Pretreatments of red blood cells lysates 
Red blood cells (RBCs) lysates were prepared from blood as described in the 
Supporting Information34.  
The RBCs lysates were precipitated with ethanol-chloroform to deplete 
hemoglobin as described elsewhere34, with some changes: 350 µL of cold ethanol and 
200 µL of cold chloroform were added to 250 µL of RBCs lysate. The mixture was 
shaken for 5 min at 4ºC and centrifuged at 3000 g for 10 min at 4ºC. The supernatant 
was collected and low Mr compounds were removed with 10,000 Mr cut-off (MWCO) 
cellulose acetate centrifugal filters (Amicon Ultra-0.5, Millipore).  
Thermo-enrichment to deplete the non-thermostable proteins was performed on 




in a thermoshaker. The mixture was centrifuged at 12000 g for 5 min at 4ºC and the 
supernatant (i.e. thermo-enriched (TE) RBCs lysate) was filtered using a 0.22 µm 
polyvinylidene difluoride centrifugal filter (Ultrafree-MC, Millipore, Bedford, MA, 
USA) at 12000 g for 5 min. 
 
Apparatus  
pH measurements were made with a Crison 2002 potentiometer and a Crison 
electrode 52-03 (Crison Instruments, Barcelona, Spain). Agitation was performed with a 
Vortex Genius 3 (Ika®, Staufen, Germany). Centrifugal filtration was carried out in a 
Mikro 220 centrifuge (Hettich Zentrifugen, Tuttlingen, Germany). Incubations were 
carried out in a TS-100 thermoshaker (Biosan, Riga, Latvian Republic). A neodymium 
cube magnet (12 mm, N48) was supplied by Lab on a Bead. 
 
CE-MS 
Fused silica capillaries were supplied by Polymicro Technologies (Phoenix, AZ, 
USA). All CE-MS experiments were performed in a 7100 CE coupled with an 
orthogonal G1603A sheath-flow interface to a 6220 oa-TOF LC/MS spectrometer 
(Agilent Technologies, Waldbronn, Germany). ChemStation and MassHunter softwares 
(Agilent Technologies) were used for the CE and TOF mass spectrometer control, data 
acquisition and processing. The TOF mass spectrometer was operated in ESI+ mode 
and the optimized parameters are presented in the Supporting Information. 
Separations were performed at 25°C in a 72 cm long (LT) × 75 µm i.d. × 365 µm 
o.d. capillary. All capillary rinses were performed flushing at 930 mbar. For new 
capillaries or between workdays, the capillaries were flushed off-line with 1 M NaOH 




unnecessary contamination of the MS system. Samples were hydrodynamically injected 
at 50 mbar for 10 s (54 nL, i.e. 1.7% of the capillary, estimated using the  Hagen–
Poiseuille equation35), ,and a separation voltage of +25 kV (normal polarity, cathode in 
the outlet) was applied. The autosampler was kept at 10°C using an external water bath 
(Minichiller 300, Peter Huber Kältemaschinenbau AG, Offenburg, Germany). Between 
runs, the capillary was conditioned flushing with water (2 min) and BGE (2 min). 
 
AA-SPE-CE-MS 
AA-MBs were prepared following the manufacturer recommendations. First, a 
200 µL aliquot of MBs solution was vortexed and the supernatant was removed after 
magnetic separation, using a cube magnet to sediment the particles (20 µL of 
sedimented MBs). The MBs were washed using 200 µL of PBS with 0.1% Tween® 20 
(PBS-T), the supernatant was removed by magnetic separation and the MBs 
resuspended with the same volume of PBS-T. Ten µL of activation buffer was added 
and the MBs were moderately shaken for 15 min at room temperature. The supernatant 
was removed by magnetic separation, the MBs were washed with 200 µL of PBS-T and 
resuspended with 150 µL of PBS-T. Fifty µL of the DNA aptamer M5-15-5’amino 
dissolved in PBS (100 µmol·L-1) was then added to the MBs suspension. The mixture 
was moderately shaken for 40 min at room temperature. The supernatant was removed 
and the AA-MBs were subsequently washed three times with 200 µL of PBS and 
resuspended with the same volume of PBS. The remaining reactive groups on AA-MBs 
were blocked adding 20 µL of blocking buffer (50% (v/v) ethanolamine in PBS) and the 
mixture was moderately shaken for 45 min at room temperature. Finally, the 




200 µL of PBS. The AA-MBs were stored in PBS with 20% (v/v) ethanol at 4ºC when 
not in use. 
Construction of fritless particle-packed microcartridges for AA-SPE-CE-MS 
was carried out as described elsewhere, taking advantage of the average larger size of 
the sorbent particles compared to the inner diameter of the separation capillary9,13,36. 
The microcartridge (0.9 cm LT × 250 µm i.d. × 365 µm o.d. capillary) was completely 
filled by vacuum with AA-MB sorbent and connected with plastic sleeves to two 
capillary fragments (7.5 cm LT × 75 µm i.d. × 365 µm o.d. (inlet) and 64.5 cm LT × 75 
µm i.d. × 365 µm o.d. (outlet)), which were conditioned before beginning the 
construction. 
Under the optimized conditions, AA-SPE-CE-MS capillaries were first 
conditioned flushing with BGE at 930 mbar for 2 min. Samples were introduced at 930 
mbar for 5 min (30 µL35). A final flush with BGE for 2 min eliminated nonretained 
molecules and filled the capillary before the electrophoretic separation. All these steps 
were performed with the nebulizer gas and the ESI capillary voltage switched off to 
prevent the entrance of contaminants into the MS. Then, both were switched on and a 
small volume of eluent with 100 mM NH4OH (pH 11.2) was injected at 50 mbar for 20 
s (100 nL35). For a rapid and repeatable protein elution, the small plug of eluent was 
pushed with BGE at 50 mbar for 100 s, before applying the separation voltage (+25 kV) 
and a small pressure (25 mbar) to compensate for the microcartridge counter-pressure. 
Between consecutive runs, to avoid carry-over, the capillary was flushed with water for 
1 min, eluent was injected at 50 mbar for 40s, and the capillary was flushed again with 






Quality parameters  
The details regarding the limit of detection (LOD), limit of quantification 
(LOQ), repeatability of migration time and peak area, linearity, and microcartridge 
lifetime in CE-MS and AA-SPE-CE-MS are given in the Supporting Information. 
 
LC-Orbitrap-MS/MS  
The details about TE RBCs lysate bottom-up proteomics workflow including 
LC-Orbitrap-MS/MS analysis are given in the Supporting Information. 
 
Results and discussion 
CE-MS  
In general, the best results for the analysis of intact proteins by CE-MS in ESI+ 
are obtained using acidic volatile BGEs and sheath liquids because protein ionization is 
maximized and the best sensitivity is achieved. Different conditions were tested for the 
analysis of recombinant human α-syn (i.e. 50 mM HAc: 50 mM HFor (pH 2.3); 100 
mM HAc (pH 2.9) or 10 mM NH4Ac (pH 7.0, 8.0 or 9.0) as BGEs combined with 60:40 
(v/v) propan-2-ol/water with 0.05 or 0.25% (v/v) of HFor as sheath liquids). The best 
results for the analysis of α-syn were obtained with a BGE of 100 mM HAc (pH 2.9) 
and a sheath liquid of 60:40 (v/v) propan-2-ol/water with 0.05% (v/v) of HFor. As an 
example, Figure 1 shows the extracted ion electropherogram (EIE) (A), mass spectrum 
(B) and deconvoluted mass spectrum (C) for the CE-MS analysis of a 100 µg·mL-1 
standard solution of recombinant human α-syn in the optimized conditions. The only 
detected proteoform was free α-syn because the recombinant human α-syn expressed in 
E. coli was not supposed to undergo post-translational modifications (PTMs) during 




are mostly due to Na+ and K+ adducts to the ion species of the mass spectrum of Figure 
1-B). Table S-1 shows the theoretical average Mr of free α-syn and the relative error (Er) 
for the experimental deconvoluted average Mr. Mass accuracy was good (Er<20 ppm). 
Under the optimized conditions, consecutive analyses of the α-syn standard were 
repeatable in terms of migration time and peak area (%RSD (n=3) were 0.9 and 5.6% at 
100 µg·mL-1). The LOD was 20 µg·mL-1, better than the 50 µg·mL-1  LOD by CE-MS 
using a BGE of 10 mM NH4Ac (pH 7.0) and a sheath liquid of 60:40 (v/v) propan-2-
ol/water with 0.25% (v/v) of HFor. These latter conditions are typically required to 
analyze proteins by IA-SPE-CE-MS12,13. 
 
AA-SPE-CE-MS optimization 
The DNA aptamer M5-15 was selected to prepare the aptamer affinity (AA) sorbent 
because it has been described to selectively bind with high affinity to α-syn monomer32. 
In contrast to our previous studies by IA-SPE-CE-MS12,13, it was observed that in AA-
SPE-CE-MS the AA sorbent was stable even using acidic BGEs. Sensitivity and 
repeatability were investigated with different combinations of BGE and sheath liquid 
(see below), using a basic volatile eluent of 100 mM NH4OH (pH 11.2)
12,13. Using a 
sheath liquid of 60:40 (v/v) propan-2-ol/water with 0.05% (v/v) of HFor, a BGE of 100 
mM HAc (pH 2.9) allowed obtaining similar peak areas to a BGE of 50 mM HAc: 50 
mM HFor (pH 2.3). However, in the second case, a slight decrease of peak areas was 
detected after consecutive injections, probably because of AA sorbent deterioration due 
to the lower pH value. Using the basic eluent, the acidic BGEs provided higher 
sensitivity than the BGEs of 10 mM NH4Ac at pH 7.0, 8.0 or 9.0, even with a sheath 
liquid of 60:40 (v/v) propan-2-ol/water with an increased amount of HFor (i.e. 0.25% 




10 mM NH4Ac and an eluent of 100 mM HAc (pH 2.9) were tested and no α-syn was 
detected. Therefore, the BGE of 100 mM HAc (pH 2.9) was selected for the rest of the 
experiments. 
The investigation of the volatile eluents was extended, testing different 
hydroorganic mixtures in the presence or absence of 100 mM NH4OH. First, 
acetonitrile:water mixtures at 40% and 80% (v/v) were tested to disrupt analyte-aptamer 
interaction14,23. However, these acetonitrile:water eluents were rapidly discarded 
because electropherograms and mass spectra were extremely poor, probably due to 
sorbent deterioration during the elution. Results with 60% (v/v) MeOH in the presence 
or absence of 100 mM NH4OH were neither satisfactory as shown in Figure 2A. The 
best sensitivity and repeatability of peak areas and migration times were obtained with 
the aqueous basic eluent of 100 mM NH4OH (pH 11.2). A higher concentration than 
100 mM of NH4OH in the aqueous eluent was not tested to prevent aptamer 
denaturation and expand the sorbent lifetime. The volume of the eluent plug was 
investigated injecting the eluent at 50 mbar for 10, 20 and 40 s (50, 100 and 200 nL35). 
A higher amount of α-syn was detected injecting the eluent 20 s instead of 10 s. 
However, for the 40 s eluent injection, the analyte peak broadened, and peak area 
decreased. Between consecutive runs of a 10 µg·mL-1 α-syn standard solution, a small 
amount of α-syn was detected as carry-over when only rinsing with water between 
injections. Therefore, to prevent carry-over, the capillary was rinsed with water, a small 
plug of eluent, and again water between injections. 
With regard to the sample loading, the standard solutions were prepared in water 
because lower peak areas were observed when using PBS, probably due to the smaller 
binding efficiency in a salty environment. The sample loading time was studied 




be seen in Figure 2B, the maximum amount of α-syn was detected at around 5 min. 
When loading for a longer time, the sample breakthrough volume was exceeded and the 
α-syn washed away was higher than the amount retained, causing a significant decrease 
of peak area. Therefore, to reduce the total analysis time and to obtain the highest 
recoveries, a sample loading time of 5 min was selected for the rest of the experiments.  
Under the optimized conditions, consecutive analyses of the standard were 
repeatable in terms of migration time and peak area. At 1 µg·mL-1, the %RSDs (n=3) 
were 2.1 and 5.4%, respectively, similar to the values in CE-MS. As can be seen in 
Figure 2C, the method was satisfactorily linear (R2>0.994) between 0.5 and 10 µg·mL-1. 
The LOQ was 0.5 µg·mL-1 and the LOD was 0.2 µg·mL-1, which was an improvement 
of about 100 times compared to the CE-MS method. The lifetime of the microcartridges 
was around 20 analyses (at 1 µg·mL-1). As an example, Figure 1A shows the AA-SPE-
CE-MS analysis of a 1 µg·mL-1 α-syn standard. Compared to CE-MS (Figures 1B, 1C 
and Table S-1), the mass spectrum and mass accuracy for experimental deconvoluted 
average Mr of free α-syn was similar (data not shown). 
 
Analysis of α-syn in blood samples 
The AA-SPE-CE-MS method optimized with standards was applied to the 
analysis of blood. The concentration of α-syn has been shown to be higher in blood than 
in cerebrospinal fluid (CSF) and, furthermore, drawing blood is less invasive than 
lumbar puncture to obtain CSF from patients29,30. More than 99% of the α-syn in human 
blood resides in the red blood cells (RBCs)37. N-terminal acetylation of proteins is a 
common occurrence, especially for those proteins initiated in Met residue, and this PTM 




A healthy control RBCs lysate was prepared, passed through a 0.20 µm nylon 
filter and analyzed by CE-MS and AA-SPE-CE-MS. In both cases, was detected only 
hemoglobin (Hb) (Figure S-1 and Table S-2), which constitutes around 95% of the 
protein content in the RBCs38. Therefore, to analyze low abundant proteins (i.e. 
endogenous α-syn) it was necessary to study different pretreatments to remove the most 
abundant proteins from the RBCs lysate, reducing sample complexity and the dynamic 
concentration range of the proteins. Ethanol-chloroform extraction to deplete Hb from 
the RBCs lysate was tested as in our previous work to purify superoxide dismutase from 
RBCs lysates34. With this pretreatment, Hb quantitatively precipitated from the RBCs 
lysate because Hb was not detected in the analysis of both the organic and aqueous 
phases by CE-MS. However, both phases contained other high abundant proteins that 
interfered in α-syn detection. In the analysis by CE-MS and AA-SPE-CE-MS of both 
phases, ubiquitin and N-acetylated carbonic anhydrase 1 (CA-1) were detected but not 
α-syn (Figure S-2 and Table S-2). These results were consistent with the fact that 
ethanol-chloroform extraction has been also historically used to achieve quantitative 
removal of Hb in purification of carbonic anhydrases39. However, an alternative 
purification method was necessary for α-syn. 
Taking into account that α-syn is a thermostable protein, and the solubility and 
the PTMs pattern of α-syn is not supposed to be altered upon heating27,31,40, the RBCs 
lysate was thermally treated to deplete non-thermostable proteins. With this 
pretreatment, both Hb and CA-1 were removed from the RBCs lysate but endogenous 
α-syn was not detected by CE-MS. Only ubiquitin and apolipoprotein A-I, which were 
highly abundant in the RBCs38,41, were detected (Figure S-3 and Table S-2). With 
regard to the analysis of the TE RBCs lysate by AA-SPE-CE-MS (Figure 3), it was 




(Figure 3C), which is a highly consistent value with the expected average Mr for N-
acetylated α-syn (Mr 14,502.06; Table S-1). In order to check if N-terminal acetylation 
of endogenous α-syn significantly affected the electrophoretic mobility of the protein 
and was causing the increase on migration time compared to the standard in water (~10 
min increase), a TE RBCs lysate sample spiked with 0.3 µg·mL-1 of free α-syn standard 
was analyzed (recovery for free α-syn was 86%, by comparison of the AA-SPE-CE-MS 
analyses for the standard and the spiked sample at 0.3 µg·mL-1). As can be observed in 
Figure 4A, free α-syn and N-acetylated α-syn comigrated. However, the excellent mass 
accuracy and resolving power of the mass spectrometer allowed to unambiguously 
identify both proteoforms in the deconvoluted mass spectrum of Figure 4-C (Mr=+42) 
and to obtain separate EIEs (Figure 4A). With regard to the migration time increase 
detected in TE RBCs lysates, it was probably due to the modification of the inner wall 
of the separation capillary induced during sample loading by the non-retained 
components of the complex sample matrix. This modification happened after the first 
analysis with a new microcartridge and was permanent, because repeatability was high 
(see the quality parameters below). Another proof of this permanent modification was 
that free α-syn was also detected at this increased migration time when a standard α-syn 
solution was analyzed after a TE RBCs lysate sample.  
As can be also observed in Figures 3 and 4, N-acetylated α-syn slightly 
comigrated with ubiquitin, which was also retained by the AA sorbent. In addition to 
ubiquitin, very small amounts of apolipoprotein A-I were detected (Figure S-4). Several 
experiments were made to investigate non-specific adsorption on the AA sorbent. It is 
worth highlighting that compared to the typical aptamer- or antibody-based biosensors 
or bioassays, a great advantage of AA-SPE-CE-MS is that the electrophoretic separation 




erroneous quantification of the target protein in the presence of non-specific adsorption. 
A microcartridge containing blank sorbent (i.e. activated and endcapped MBs, without 
aptamer) was tested by SPE-CE-MS. When loading a 1 µg·mL-1 α-syn standard solution 
a very small amount of α-syn was detected (6.4% compared to the AA sorbent). This 
suggested that non-specific adsorption of α-syn was very limited because it was not 
efficiently retained by the endcapped sorbent without aptamer, hence also confirming 
that the aptamer was required for the binding of α-syn. In contrast, when the TE RBCs 
lysates were analyzed with the blank sorbent, only ubiquitin, in a similar amount to that 
observed by AA-SPE-CE-MS, was detected. To deplete ubiquitin from the TE RBCs 
lysate before the analysis by AA-SPE-CE-MS, the sample was incubated off-line with 
blank sorbent. However, no significant differences were observed. Results were also 
unsatisfactory in separate experiments, when a great concentration of off-target 
sequence single-stranded DNA (i.e. 200 nM) was added to the TE RBCs lysate for 
masking. Non-specific adsorption of ubiquitin on the endcapped solid support was 
probably promoted by its high abundance in the TE RBCs lysate41, but a certain affinity 
to the α-syn aptamer could not be discarded. Once ruled out the possibility of reducing 
the amount of ubiquitin in the TE RBCs lysate, a 50 µm i.d. separation capillary was 
tested to improve the separation resolution between α-syn and ubiquitin. However, 
loading the TE RBCs lysate for AA-SPE-CE-MS promoted capillary blockage and 
current breakdowns during the separations, due to the complexity of the sample matrix 
and capillary narrowness. Therefore, the 75 µm i.d. separation capillary was necessary 
to analyze the TE RBCs. Under the optimized conditions, consecutive analyses of the 
TE RBCs lysate by AA-SPE-CE-MS were repeatable in terms of migration times and 
peak areas (%RSDs (n=3) were 6.7 and 10.8%, respectively) and the lifetime of the 




higher sample matrix complexity. The estimated concentration of the endogenous N-
acetylated α-syn detected in the TE RBCs lysate was 0.6 µg·mL-1, calculated by 
comparison of the AA-SPE-CE-MS analyses for non-spiked and spiked samples with 
free α-syn standard at 0.3 µg·mL-1. 
The developed AA-SPE-CE-MS method was applied to the analysis of TE RBCs 
lysate samples from blood of healthy controls and Parkinson’s disease (PD) patients 
with stage III or IV of the disease. In both healthy controls and PD patients, ubiquitin 
and N-acetylated α-syn were detected, but no other α-syn proteoforms, including PTMs 
or C-terminal truncated forms. To complement and validate the results at the intact 
protein level by AA-SPE-CE-MS and the limited information obtained about the most 
abundant proteins of the differently pretreated RBCs lysates by CE-MS without on-line 
AA-SPE (Table S-2), the TE RBCs lysate samples were digested with trypsin and 
analyzed by LC-Orbitrap-MS/MS. As can be seen in Table S-3, this bottom-up indirect 
approach provided more information, which resulted in the identification of 156 
proteins in both groups of samples (no significant differences were found between PD 
patients and controls). The most relevant identified proteins in accordance to emPAI 
values were: hemoglobin subunit alpha, N-acetylated α-syn, which was the only α-syn 
proteoform detected, apolipoprotein A-I, hemoglobin subunit beta, and apolipoprotein 
A-IV. Considering these results, the most probable form of the detected ubiquitin was 
ubiquitin-40S ribosomal protein S27a (P62979). Furthermore, it was confirmed the 
great complexity of the TE RBCs lysate, as well as that N-acetylated α-syn was the 
main α-syn proteoform in RBCs. Therefore, the abundance of other minor proteoforms 
in RBCs from healthy controls and PD patients might be very low, in agreement with 
recent reports28,31. However, a larger set of samples must be analyzed to confirm this 




presence of a high abundance of these typically very minor proteoforms, has been only 
confirmed for phosphorylated α-syn at Ser-129 in LB deposited in the brain of patients 
with different synucleinopathies, including PD25,26. 
 
Concluding remarks 
We have developed an on-line AA-SPE-CE-MS method for the purification, 
preconcentration, separation, and characterization of blood α-syn. Under the optimized 
conditions with standards, microcartridge lifetime (around 20 analyses/microcartridge) 
and repeatability (2.1 and 5.4 %RSD for migration times and peak areas) were good, the 
method was linear between 0.5 and 10 µg·mL-1 and LOD was 0.2 µg·mL-1 (100 times 
lower than by CE-MS, 20 µg·mL-1). Regarding the analysis of blood samples, an off-
line thermal pretreatment was necessary to remove the most abundant proteins in RBCs 
lysate. The AA-SPE-CE-MS method performed also reasonably well for the analysis of 
RBCs lysates despite the complexity of the sample matrix. However, repeatability was 
slightly smaller (%RSDs (n=3) were 6.7 and 10.8% for migration times and peak areas, 
respectively), microcartridge lifetime was shorter (around 10 analyses/microcartridge), 
total analysis times increased 10 minutes and non-specific adsorption of mainly 
ubiquitin was observed. In view of the results achieved, because of the high affinity to 
bind to the target molecule and the improved tolerance to acidic and basic conditions, 
immobilized aptamers can be regarded as a powerful alternative to antibodies for SPE-
CE-MS. With regard to the clinical implications of the case study, in the RBCs lysate N-
acetylated α-syn was detected to be the main proteoform in healthy controls and stage 
III-IV PD patients, and no other minor proteoforms were detected. Therefore, no 
apparent alteration of blood α-syn proteoforms at the level of a few hundreds of ng·mL-1 




to confirm this preliminary finding. Furthermore, the developed AA-SPE-CE-MS 
method could be applied to the analysis of α-syn from LBs isolated from the brain of 
patients with different synucleinopathies to screen for characteristic α-syn proteoforms. 
 
Supporting Information 
Preparation of RBCs lysates, optimized MS parameters, quality parameters, LC-
Orbitrap-MS/MS analysis, Mr of the detected proteins, AA-SPE-CE-MS for filtered 
RBCs lysate and for ethanol-chloroform extracted RBCs lysate, CE-MS and AA-SPE-
CE-MS for TE RBCs lysate and most relevant detected proteins in TE RBCs lysates 
after digestion with trypsin and LC-Orbitrap-MS/MS analysis. 
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Figure 1. CE-MS and AA-SPE-CE-MS for a 100 and a 1 µg·mL-1 α-syn standard, 
respectively. (A) Extracted ion electropherograms (EIEs), (B) mass spectrum of the 






















Figure 2. (A) Peak area of the detected α-syn for a 1 µg·mL-1 α-syn standard loaded for 
5 min at 930 mbar in water by AA-SPE-CE-MS using different eluents and a BGE of 
100 mM HAc (pH 2.9). (B) Plot of peak area of the detected α-syn vs loading time at 
930 mbar (1 µg·mL-1 α-syn standard in water, using the optimized elution and 
separation conditions). (C) Plot of peak area of the detected α-syn vs concentration of 
the loaded standard solution, regression line and R2 value using the optimized loading, 
elution and separation conditions. All measurements were performed in triplicate 
(standard deviation is given as error bars; %RSD for migration times is given in 

















Figure 3. AA-SPE-CE-MS for a thermo-enriched red blood cells (TE RBCs) lysate 
sample. (A) Extracted ion electropherogram (EIE), (B) mass spectrum of the boxed time 
region, and (C) deconvoluted mass spectrum. In addition to ubiquitin, very small 
















Figure 4. AA-SPE-CE-MS for a thermo-enriched red blood cells (TE RBCs) lysate 
sample spiked with 0.3 µg·mL-1 of free α-syn standard. (A) Extracted ion 
electropherograms (EIEs) for N-acetylated α-syn (purple) and free α-syn (red), (B) mass 
spectrum of the boxed time region, and (C) deconvoluted mass spectrum (see the 
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Preparation of red blood cells (RBCs) lysates  
Fresh blood was obtained by venipuncture and was collected into 4 mL BD 
Vacutainer® K2EDTA Plus blood collection tubes (Plymouth, UK) to prevent 
coagulation. The plasma and the buffy coat were separated from the red blood cells 
(RBCs) by centrifugation at 500 g for 10 min at 4ºC. RBCs were aliquoted at 250 µL in 
Protein LoBind 1.5 mL Tubes (Eppendorf, Hamburg, Germany), and were washed three 
times with 250 µL of cold isotonic 0.1 M NaCl and centrifuged at 500 g for 5 min at 
4ºC. Washed RBCs from healthy controls and PD patients were separately pooled, 
aliquoted and stored at -80ºC until further use. To obtain the RBCs lysate, 600 µL of 
ice-cold water was added to 200 µL of the washed RBCs. The mixture was shaken for 
10 min, and centrifuged at 6000 g for 10 min at 4ºC. The supernatant (i.e. RBCs lysate) 
was collected and the membranes were discarded. 
 
Optimized MS parameters 
The TOF-MS parameters were optimized analyzing by CE-MS a 100 µg·mL-1 α-
syn standard solution: capillary voltage 4000 V, drying gas temperature 300 ºC, drying 
gas flow rate 4 L·min-1, nebulizer gas 7 psig, fragmentor voltage 325 V, skimmer 
voltage 80 V, OCT 1 RF Vpp voltage 300 V. Data were collected in profile at 1 
spectrum/s between 100 and 3200 m/z, with the mass range set to high resolution mode 
(4 GHz).  
 
Quality parameters 
All quality parameters were calculated from data obtained by measuring 
migration time (tm) and peak area from the extracted ion electropherogram (EIE) of α-
syn proteoforms (considering the m/z of the most abundant molecular ions, i.e. ions with 
charges +16, +15, +14, +13). Repeatability was evaluated as the percent relative 
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standard deviation (%RSD) of tm and peak areas. The LOD was obtained by analyzing 
low-concentration standard solution of α-syn (close to the LOD level, as determined 
from a S/N=3). LOQ was determined from a S/N=10. Linearity range was established 
by analyzing standard solutions of α-syn at concentrations between 0.2 and 20 µg·mL-1. 
The lifetimes of the microcartridges were investigated by repeatedly analyzing a 1 
µg·mL-1 standard solution of α-syn and thermoenriched (TE) RBCs lysate samples. The 
microcartridge was discarded when the peak of α-syn in the EIE decreased more than 




One-hundred µL of TE RBCs lysate was evaporated to dryness using a Savant 
SPD-111 V SpeedVac concentrator (Thermo-Fisher Scientific, Waltham, MA, USA) 
and suspended in 100 µL of ice-cold extraction buffer (25 mM HEPES (pH 8.0), 1.5 M 
urea, 0.02% Triton X-100 and 5% (v/v) glycerol). The suspension was vortexed for 2 
min and centrifuged for 30 s at 5000 g. Samples were reduced by addition of 3 mM 
tris(2-carboxyethyl)phosphine (TCEP) for 45 min at room temperature then alkylated 
with 15 mM iodoacetamide for 60 min in the dark at room temperature. Proteolytic 
digestion was performed by addition of 500 ng of Trypsin/Lis-C solution (Promega, 
Madison, Wisconsin, USA) and incubated under shaking at 500 rpm at ambient 
temperature overnight. The digestion was stopped by addition of formic acid (1% final 
concentration) and centrifuged at 15000 g for 2 minutes. The supernatant of digested 
proteins was desalted on disposable TopTip C-18 columns (Glygen, Columbia, MD, 
USA) and was evaporated to dryness. 
All experiments were performed on an Orbitrap Fusion (Thermo Scientific) 
coupled to an Ultimate3000 nanoRLSC (Thermo Scientific). Protein digests were 
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reconstituted in 10 µL of 70% acetonitrile (ACN)/ 0.1% formic acid and separated on an 
in-house packed column (15 cm x 75 µm i.d. x 365 µm o.d. fused silica capillary, 
Polymicro Technologies) packed with C18 particles (Luna C18(2), 3 µm, 100 Å, 
Phenomenex, Torrance, California, USA) using a water/ACN/0.1% formic acid linear 
gradient at a flow rate of 0.30 µL/min (0-7 min, 2-2% ACN; 7-77 min, 2-38% ACN; 77-
86 min, 38-98% ACN; 86-96 min, 98-98% ACN; 96-99 min, 98-2% ACN; 99-109 min, 
2-2% ACN). Two µL of sample were injected.  
The Orbitrap-MS/MS parameters in ESI+ were as follows: ion source 
temperature 250 °C, ionspray voltage 2.1 kV, top speed mode, full-scan MS spectra 
(m/z 350–2000) acquired at a resolution of 60,000. Precursor ions were filtered 
according to monoisotopic precursor selection, charge state (+2 to +7), and dynamic 
exclusion (30 s with a ± 10 ppm window). The automatic gain control settings were 
4*105 for full FTMS scans and 1*104 for MS/MS scans. Fragmentation was performed 
with collision-induced dissociation (CID) in the linear ion trap. Precursors were isolated 
using a 2 m/z isolation window and fragmented with a normalized collision energy of 
35%.  
Proteome discoverer 2.1 (Thermo Scientific) was used for protein identification. 
The precursor mass tolerance was set at 20 ppm and 0.6 mass tolerance for fragment 
ions. Search engine: SEQUEST-HT implemented in Proteome Discovery was applied 
for all MS raw files. Search parameters were set to allow for dynamic modification of 
methionine oxidation, acetyl on N-terminus, phosphorylation on serine, threonine and 
tyrosine, nitration of tyrosine and cysteine carbamidomethylation. The search database 
consisted of a nonredundant human protein sequence FASTA file from the 
UniProt/SwissProt database. The false discovery rate (FDR) was set to 0.05 for both 
peptide and protein identifications. 
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Six digested TE RBCs lysate samples were analyzed with two replicates of each 
sample. Proteins identified with “low” or “medium” protein confidence values or 
detected in less than 9 of the 12 analyses were not reported. 
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Table S-1. Theoretical and deconvoluted average Mr for the detected α-syn proteoforms in recombinant human α-syn standard 






Deconvoluted average Mr  
Experimental Era) (ppm) 
Recombinant human α-syn standard Free α-syn 14,460.02 14,459.82 -14 
TE RBCs lysate N-acetylated α-syn  14,502.06 14,502.14 6 
a) Relative error (Er) was calculated in ppm as: (Mr exp – Mr theo)/Mr theo × 106 (exp = experimental and theo = theoretical). Mr exp was obtained 
as an average of three replicates. 
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P69905 15,126.20 15,126.29 6 X   X    
Hemoglobin 
subunit beta 
P68871 15,867.05 15,866.67 -24 X   X    
Ubiquitin P62979b) 8564.76c) 8564.91 17  X X  X X X 
N-acetylated 
carbonic 
anhydrase 1  
P00915 28,780.75 28,780.78 1  X   X   
Apolipoprotein 
A-I 
P02647 28,078.33 28,078.13 -7   X   X  
N-acetylated 
α-syn  
P37840 14,502.06 14,502.14 -6      X  
a) Relative error (Er) was calculated in ppm as: (Mr exp – Mr theo)/Mr theo × 106 (exp = experimental and theo = theoretical). Mr exp was obtained as an average of three 
replicates. 
b) This Uniprot accession number corresponds to ubiquitin-40S ribosomal protein S27a and was assigned taking into account the results of the LC-Orbitrap-MS/MS 
analysis (see Table S-3).  
c) This Mr value agrees with a fragment (1-76) of P62979 protein. This fragment is also found in Uniprot accession numbers P0CG47 (polyubiquitin-B), P0CG48 





Figure S-1. AA-SPE-CE-MS for a filtered RBCs lysate. (A) Total ion electropherogram 





Figure S-2. AA-SPE-CE-MS for an ethanol-chloroform extracted RBCs lysate. (A) 
Total ion electropherogram (TIE), (B) extracted ion electropherograms (EIEs), and (C) 







Figure S-3. CE-MS for a TE RBCs lysate. (A) Total ion electropherogram (TIE), (B) 






Figure S-4. AA-SPE-CE-MS for a TE RBCs lysate. (A) Total ion electropherogram 
(TIE), (B) extracted ion electropherograms (EIEs), and (C) deconvoluted mass 
spectrum. N-acetylated α-syn was also detected (see Figure 3). 
 
